Caregiving Tasks Fluctuate between Urgent and Necessary
One of the greatest privileges of my life was to care for my mother, who had Alzheimer’s disease. However, I was constantly fighting an ... Read more
Updates
-
-
Protein Treatment, GRF6019, Seen to Help Maintain Cognition in Alzheimer’s Patients in Phase 2 Trial
Alkahest’s experimental blood-derived protein GRF6019 helps maintain cognition and function in mild to moderate Alzheimer’s disease patients, results of a six-month Phase 2 clinical trial ... Read more -
AC Immune’s Anti-Tau Vaccine ACI-35.030 to Be Tested in Phase 1b/2a Trial
AC Immune is launching a Phase 1b/2a clinical trial to evaluate an investigational anti-tau vaccine called ACI-35.030 as a potential disease-modifying treatment for Alzheimer’s disease ... Read more -
Self-talk Your Way to a Positive Outlook
Have you heard the saying, “Talking to yourself is OK as long as you don’t expect a response”? Most of us do it, and ... Read more
-
UAFS, Arkansas Senior Residence Use 3D Technology to Aid Recreational Therapy
To foster the cognitive stimulation of its Alzheimer’s disease (AD) residents, an Arkansas senior ... -
AZTherapies Completes Enrollment for ALZT-OP1 Trial for Early Alzheimer’s
AZTherapies has completed enrollment for its Phase 3 COGNITE trial, testing the safety and ... -
Chemical Compound Can Restore Neural Function in Familial Alzheimer’s, Study Finds
A mutation in a gene linked to familial Alzheimer’s disease promotes the disease ... -
Maintaining Friendships Is Challenging for Caregivers and Those with Alzheimer’s
This week people around the world celebrated International Day of Friendship. In 2011, the ... -
$47M Federal Grant Adds Brain Imaging to Pivotal Lifestyle Interventions Study
The University of California, Berkeley (UC Berkeley) will receive an expected $47 million in ... -
Longeveron Gets $3M Alzheimer’s Association Grant to Continue Stem Cell Study
Biopharmaceutical company Longeveron will use a $3 million Alzheimer’s Association grant to advance innovative ...
Subscribe to our mailing list
Get regular updates delivered to your email box.
Thanks! Please check your email for a confirmation email.
Anavex ‘Cautiously Optimistic’ After Noting Cognitive Improvement in Alzheimer’s Treatment
News
Anavex Life Sciences says its Alzheimer’s drug candidate Anavex 2-73 may have a role in treating the disease. Data from a long-term extension trial, although small, indicated that the therapy improved cognitive and functional measures in patients. According to data ... Read more